Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 9 open reading frame 122 pseudogene (C9orf122 pseudogene, ENSG00000253884) is a predicted, non-coding pseudogene located on human chromosome 9. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to disabling mutations or lack of regulatory elements[3][4][2]. This pseudogene does not encode a functional protein and is not a receptor, enzyme, transporter, or other typical drug target. There is no evidence for clinical, biomarker, or therapeutic relevance for this entity. Its biotype relates to processed or unprocessed pseudogenes, which can sometimes be transcribed but do not translate to functional protein[3][6]. No aliases refer to established pathways or molecular functions, and it is generally omitted from pharmacological and clinical utility databases.
None (not a known drug target[2][3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 122 pseudogene (C9orf122 pseudogene).